Bioharvest Sciences (BHST) Capital Leases (2023 - 2025)

Bioharvest Sciences' Capital Leases history runs 3 years deep, the most recent figure standing at $10.1 million for Q4 2025.

• On a quarterly basis, Capital Leases rose 10.82% year-over-year to $10.1 million in Q4 2025; TTM through Dec 2025 was $10.1 million, a 10.82% increase from a year earlier, with the FY2025 full-year figure at $10.1 million, up 10.82% from the prior year.
• Capital Leases advanced to $10.1 million in Q4 2025 per BHST's latest filing, from $9.1 million in the prior quarter.
• Across five years, Capital Leases topped out at $10.1 million in Q4 2025 and bottomed at $1.4 million in Q4 2023.
• The 3-year median for Capital Leases is $9.1 million (2024), against an average of $6.9 million.
• Across the five-year window, Capital Leases soared 541.47% in 2024 and grew 10.82% in 2025, its largest moves.
• Year by year, Capital Leases stood at $1.4 million in 2023, then surged by 541.47% to $9.1 million in 2024, then rose by 10.82% to $10.1 million in 2025.
• Per Business Quant, the three latest BHST Capital Leases figures stand at $10.1 million (Q4 2025), $9.1 million (Q4 2024), and $1.4 million (Q4 2023).